[Mucocutaneous lymph node syndrome or Kawasaki disease].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D005260:Female; D006331:Heart Diseases / Q000209:etiology; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007564:Japan; D008206:Lymphatic Diseases / Q000453:epidemiology*; D008297:Male; D008875:Middle Aged; D009080:Mucocutaneous Lymph Node Syndrome / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology*; D011241:Prednisone / Q000627:therapeutic use; D014481:United States; D014859:Warfarin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D014859:Warfarin; D001241:Aspirin; D011241:Prednisone
Síndrome mucocutáneo ganglionar o enfermedad de Kawasaki.